FCGRT and chronic inflammatory demyelinating polyradiculoneuropathy: IVIg treatment is ineffective in up to 30% of patients with neuroinflammatory diseases, such as CIDP, MG, or multifocal motor neuropathy, and FcRn biology might contribute to these outcomes.